MSCGX
Price
$10.15
Change
+$0.20 (+2.01%)
Updated
Apr 24 closing price
Net Assets
1.48B
VSCIX
Price
$103.14
Change
+$2.18 (+2.16%)
Updated
Apr 24 closing price
Net Assets
143.36B
Ad is loading...

MSCGX vs VSCIX

Header iconMSCGX vs VSCIX Comparison
Open Charts MSCGX vs VSCIXBanner chart's image
Mercer US Small/Mid Cap Equity Y3
Price$10.15
Change+$0.20 (+2.01%)
VolumeN/A
Net Assets1.48B
Vanguard Small Cap Index I
Price$103.14
Change+$2.18 (+2.16%)
VolumeN/A
Net Assets143.36B
MSCGX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSCGX vs. VSCIX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCGX is a Buy and VSCIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 143B vs. MSCGX (1.48B). VSCIX pays higher dividends than MSCGX: VSCIX (1.53) vs MSCGX (0.96). MSCGX was incepted earlier than VSCIX: MSCGX (20 years) vs VSCIX (28 years). MSCGX (1.01) is less costly to investors than VSCIX (0.04). MSCGX is a more actively managed with annual turnover of: 44.00 vs. VSCIX (12.00). MSCGX has a lower initial minimum investment than VSCIX: MSCGX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : -2.34 vs. MSCGX (-11.42). VSCIX return over 5 years is better than : 71.79 vs. MSCGX (24.38).
MSCGXVSCIXMSCGX / VSCIX
Total Expense Ratio0.550.041,375%
Annual Report Gross Expense Ratio1.010.042,525%
Fund Existence20 years28 years-
Gain YTD-11.240-12.24092%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.48B143B1%
Annual Yield % from dividends0.961.5363%
Returns for 1 year-11.42-2.34488%
Returns for 3 years-10.094.74-213%
Returns for 5 years24.3871.7934%
Returns for 10 years-14.2879.11-18%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DSGN4.240.17
+4.18%
Design Therapeutics
HEI247.214.51
+1.86%
HEICO Corp
RUSHB59.301.01
+1.73%
Rush Enterprises
WVE6.79N/A
N/A
Wave Life Sciences Ltd
CSLR1.80N/A
N/A
Complete Solaria